Big News: Adjuvant Ipi Improves Survival in Melanoma

Dr Caroline Robert reviews melanoma highlights from ESMO 2016, focusing on results of ipilimumab in the adjuvant setting and the highest 3-year survival achieved in metastatic disease.

Source: Medscape Oncology - October 17, 2016 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts